<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Germline p53 mutations are associated with <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>) and other <z:e sem="disease" ids="C1333600" disease_type="Neoplastic Process" abbrv="">familial cancer</z:e> phenotypes not fulfilling the definition for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The majority of germline p53 mutations cluster in exons 5-8, corresponding to a DNA binding domain </plain></SENT>
<SENT sid="2" pm="."><plain>We report the identification of two germline mutations and a <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> in a tetramerization domain (TD), a rare site for mutations </plain></SENT>
<SENT sid="3" pm="."><plain>The germline mutation, R342X (16915C&gt;T), and the novel mutation, R342P (16916G&gt;C), were found in a child with <z:hpo ids='HP_0006744'>adrenocortical carcinoma</z:hpo> and in a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> pediatric patient with multiple primaries </plain></SENT>
<SENT sid="4" pm="."><plain>The novel <z:hpo ids='HP_0001428'>somatic mutation</z:hpo>, R337G (16900C&gt;G), was discovered in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with transformation to <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo>, developing as the third primary in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> child </plain></SENT>
<SENT sid="5" pm="."><plain>These findings add further information on p53 TD mutations and TD contribution to <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>